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SUMMARY
A randomized double-blind study compared two methods of preventing the pain from injection of propofol,
lignocaine pre-treatment followed by propofol and lignocaine added to propofol. One hundred patients received a 
4 ml solution intravenously with a venous tourniquet for 1 minute, followed by propofol mixed with 2 ml of solution.
Patients were divided into two treatment groups of 50 patients each: 4 ml 1% lignocaine pre-treatment followed by
propofol and 2 ml saline, or 4 ml saline followed by propofol and 2 ml 2% lignocaine. Pain was assessed with 
a 100 mm visual analogue scale after induction and in recovery. The incidence of injection pain was 8% in the
propofol mixed with lignocaine group, and 28% in the lignocaine pre-treatment group. This difference is statistically
significant (P=0.017). For those patients who had pain, the mean pain score was 26.5 on induction for the propofol
with lignocaine group (n=4), while the mean score was 44.4 for the pre-treatment group (n=13). The difference was
not statistically significant (P=0.25). None of the propofol mixed with lignocaine group recalled pain, while 13 of the
pre-treatment group did so. Lignocaine pre-treatment does not improve the immediate or the recalled comfort of
patients during propofol induction when compared to lignocaine added to propofol. It is recommended that
lignocaine should be added to propofol for induction rather than given before induction.
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The aim of this study was to compare two popular
methods of reducing pain on injection of propofol:
lignocaine pre-treatment and lignocaine mixed with
propofol, at the injection and also the recall of pain
afterwards in recovery.
MATERIALS AND METHODS
Approval was obtained from the Ethics Committees
of three local hospitals and written informed consent
was obtained from 100 patients. Patients were mainly
recruited from elective colonoscopy lists, day surgical
orthopaedic and gynaecology lists. They were all ASA
physical status 1 or 2, and were expected to require at
least 100 mg propofol. They were all unpremedicated.
Exclusion criteria included patients ASA physical
status 3-5, allergy to either propofol or lignocaine, 
not fluent in English, visually impaired, receiving
opioids preoperatively, or requiring rapid sequence
induction.
All patients were instructed in the use of a 100 mm
visual analogue scale (VAS). A 20 gauge cannula was
inserted in the dorsum of the hand without being
connected to a carrier fluid. 
The patients were randomized into two groups,
Group P (n=50) received 4 ml lignocaine 1% (40 mg)
pre-treatment, followed by propofol mixed with 2 ml
saline, and Group M (n=50) received 4 ml saline pre-
treatment, followed by propofol mixed with 2 ml
lignocaine 2% (40 mg). This was achieved by indi-
vidually packaged, numbered syringes containing 4 ml
liquid in a 5 ml syringe, and 2 ml liquid in a 3 ml
syringe. Neither the patient nor the anaesthetist was
aware of the contents of the numbered syringes which
were prepared by the hospital pharmacy in a ran-
domized order. The contents of the 4 ml syringe were
given intravenously with a venous tourniquet on the
upper forearm for one minute. The 2 ml solution was
added to 200 mg propofol. Ten ml of propofol solu-
tion was injected over 10 seconds, followed by a five-
*M.B.B.S., Anaesthetic Registrar.
†F.R.C.A., F.A.N.Z.C.A., Ph.D., Director, Research and Development.
Address for reprints: Dr W. J. Russell, Department of Anaesthesia and
Intensive Care, Royal Adelaide Hospital, North Terrace, Adelaide, S.A.
5000.
Accepted for publication on March 23, 2004.second wait before the patient was asked about pain
and to mark a line on the VAS. Carrier fluid was then
connected and further drugs given to facilitate induc-
tion and intubation. No midazolam or other amnesic
was given at any stage.
Patients were asked to recall if there was pain
during injection of propofol when they had satisfied
discharge criteria in the recovery area.
Demographic data and pain scores were analysed
using the Student’s t-test. The incidence of pain was
analysed with the Fisher’s exact test. P<0.05 was
considered significant. 
RESULTS
One hundred patients were enrolled in this study,
comprising 51 males and 49 females. There were 
50 patients in each treatment group. Groups were
similar with respect to age (P=0.479) and gender 
(P>0.99) (Table 1).
The incidence of pain and pain scores on induction
and in recovery are shown in Table 2. Fewer patients
who received the mixture of propofol with lignocaine
had pain on induction (P=0.017, Fisher) and none
recalled the pain in recovery. If pain occurred, 
the severity of the pain appeared to be similar in both
groups (P=0.252).
DISCUSSION
Propofol is used widely for induction of anaes-
thesia, particularly for short uncomfortable pro-
cedures, day surgery, target controlled infusion (TCI)
and for the insertion of a laryngeal mask airway.
Severe sharp, stinging or burning pain on injection 
is a common problem affecting 28% to 90%
1,2
adults, and 28% to 85%
3,4 children. This may appear
immediately on injection or have a 10 to 20s delayed
onset. The mechanism of pain caused by propofol is
uncertain, but immediate pain may be the result of
direct irritation of afferent nerve endings within the
vein, while delayed pain may be caused by triggering
of the kinin cascade and release of kininogens
5,6. If
afferent nerve endings are involved, pre-treatment
with lignocaine may give substantial relief.
A large number of trials have identified several
factors contributing to a high incidence of pain with
propofol, and several strategies have evolved to
minimize both the incidence and severity of pain. A
recent review
7 of the efficacy of IV lignocaine 40 mg
given with a tourniquet for 30 to 120s pre-treatment
found that the number needed to treat (NNT) was 1.6
for adults (n=196, 4 studies). When the same dose is
mixed with propofol, (NNT 3.6), or given IV without
a tourniquet (NNT 4.3), it appears to be less effica-
cious. Pethidine 40 mg with tourniquet (NNT 1.9) and
metoclopramide 10 mg with tourniquet (NNT 2.2)
were the next most effective strategies, possibly due
to their local anaesthetic properties. Fentanyl, alfen-
tanil and remifentanil appear to reduce the incidence
of pain but less successfully than pethidine
7. Varying
the temperature has no effect
8,9. The size of the can-
nula has no effect but placement in a large vein in the
antecubital fossa has been shown to reduce both the
incidence and severity of pain
10.
Although Picard and Tramer
7 suggested lignocaine
pre-treatment to be more effective than lignocaine
mixed with propofol, this current study supports the
opposite view. Picard and Tramer however, did not
have a double-blind direct comparison between the
two ways of using lignocaine, but rather inferred a dif-
ference in a meta-analysis from studies using a
placebo as an alternative. Other factors could have
contributed to the score differences of the two treat-
ments. Our study is the only definitive double-blind
comparison of the two active lignocaine treatments of
which we are aware. This study found that the use of
lignocaine before the injection of propofol does not
give the patient a better chance of a comfortable
induction with propofol in spite of the theoretical
benefit of a longer time to act on the vein before the
propofol exposure. This suggests that the pain may
not be caused by direct nervous stimulation by the
propofol but rather as a secondary effect possibly by
endothelial or smooth muscle stimulation.
This study supports the mixture of lignocaine with
propofol as the more effective way of providing
analgesia during induction.
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TABLE 1
Patient demographics of the two treatment groups expressed as
mean (SD)
Lignocaine before Lignocaine with
propofol propofol
(n=50) (n=50)
Age (y) 46.4 (20.3) 49.2 (19.1)
Gender, M:F 26:24 25:25
TABLE 2
Incidence of pain and pain scores of the two treatment groups
Lignocaine before Lignocaine with
propofol propofol
(n=50) (n=50)
Incidence of pain 14 (28%) 4 (8%)
Pain scores. Mean (SD)
On induction 44.4 (27.7) 26.5 (19.7)
In recovery* 42.4 (29.7) 0
*Recall of propofol associated pain in recovery.484 P. L EE, W. J. RUSSELL
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